Irbesartan clinical trials
Also written Avapro.
How each study uses Irbesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Irbesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Sept 1997 · AVAPRO · NDA 020757 (FDA, Drugs@FDA)
- European Union
- 26 Aug 1997 · Aprovel · EMEA/H/C/000141 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
70 studies that test it; most in 2005 (9)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 2002 | 3 |
| 2003 | 7 |
| 2004 | 7 |
| 2005 | 9 |
| 2006 | 8 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 6 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 43 · Other 27
Sanofi (24) · Bristol-Myers Squibb (6) · Handok Inc. (4) · Roxane Laboratories (4) · Assistance Publique - Hôpitaux de Paris (2) · Technische Universität Dresden (2) · ANRS, Emerging Infectious Diseases (1) · Alnylam Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Hydrochlorothiazide (11) · Amlodipine (10) · Ramipril (4) · Atorvastatin (3) · Valsartan (3) · Olmesartan Medoxomil (2) · Olmesartan (2) · Zilebesiran (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Irbesartan.
- Dec 2026The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA NephropathyNot applicable · Keda Lu
Studies
Open first, then newest update. How each study uses Irbesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 70
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as AvaproHow we know
- The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA NephropathyNot yet recruitingNot applicableKeda LuNCT07360002Written as Shenqi Yishen GranulesHow we know
- The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.RecruitingNot applicableHippocration General HospitalNCT06208072Written as Irbesartan 150mgHow we know
- Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis CCompletedPhase 3ANRS, Emerging Infectious DiseasesNCT00265642Written as IrbesartanHow we know
- Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With HypercholesterolemiaWithdrawnPhase 3University of Erlangen-Nürnberg Medical SchoolNCT00152698Written as IrbesartanHow we know
- Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)CompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02597361Written as IrbesartanHow we know
- Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy VolunteersCompletedPhase 1Handok Inc.NCT05663073Written as Irbesartan/Amlodipine FDCHow we know
- Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedPhase 3Handok Inc.NCT05475665Written as Irbesartan/AmlodipineHow we know
- Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT05688098Written as IrbesartanHow we know
- A Study to Evaluate ALN-AGT01 in Patients With HypertensionCompletedPhase 1Alnylam PharmaceuticalsNCT03934307Written as IrbesartanHow we know
- Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential HypetensionCompletedPhase 2Handok Inc.NCT04488978Written as Irbesartan/AmlodipineHow we know
- Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedPhase 4SanofiNCT02842359Written as Irbesartan/atorvastatin fixed dose combinationHow we know
- A Bioequivalence Trial of Irbesartan Tablets(0.15g) in Healthy Chinese SubjectsStatus unknownPhase 1The Affiliated Hospital of Qingdao UniversityNCT05297929Written as Irbesartan TabletHow we know
- Nephropathy In Type 2 Diabetes and Cardio-renal EventsCompletedPhase 4University of Campania Luigi VanvitelliNCT00535925Written as irbesartanHow we know
- Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and IrbesartanCompletedPhase 4The Third Xiangya Hospital of Central South UniversityNCT03147677Written as IrbesartanHow we know
- Effectiveness of Avapro in Obese Normotensive/Hypertensive African AmericansStatus unknownPhase 2Augusta UniversityNCT02386293Written as IrbesartanHow we know
- Preeclampsia: A Marker for Future Cardiovascular Risk in WomenSuspendedNot applicableBrigham and Women's HospitalNCT01519297Written as IrbesartanHow we know
- Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)CompletedPhase 4University of Southern DenmarkNCT00125645Written as Irbesartan Oral TabletHow we know
- Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT01712126Written as Irbesartan and HydrochlorothiazideHow we know
- Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNot applicableRoxane LaboratoriesNCT01712139Written as Irbesartan and HydrochlorothiazideHow we know
See all 70 studies that test Irbesartan →
Given beside what is tested · 7 — Irbesartan is usual care or a partner of the new treatment
- Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic RetinopathyNot yet recruitingPhase 4Chinese PLA General HospitalNCT06660940Written as IrbesartanHow we know
- A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTerminatedPhase 3AstraZenecaNCT05056727Written as IrbesartanHow we know
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedPhase 3Astellas Pharma IncNCT00933231Written as IrbesartanHow we know
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as IrbesartanHow we know
- Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)CompletedPhase 3Sun Yat-sen UniversityNCT00657059Written as irbesartanHow we know
- Sevelamer in Proteinuric CKDCompletedPhase 2Mario Negri Institute for Pharmacological ResearchNCT01968759Written as Ramipril and IrbesartanHow we know
- A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and AtorvastatinCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT01447797Written as HCP0912 / Irbesartan and AtorvastatinHow we know
As the comparator · 13 — what is tested is compared with Irbesartan
- A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney DiseaseNot yet recruitingPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT07555054Written as IrbesartanHow we know
- A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA NephropathyNot yet recruitingPhase 2Hansoh BioMedical R&D CompanyNCT06635772Written as IrbesartanHow we know
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyCompletedPhase 3Travere Therapeutics, Inc.NCT03762850Written as irbesartanHow we know
- Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)CompletedPhase 3Travere Therapeutics, Inc.NCT03493685Written as IrbesartanHow we know
- Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental GlomerulosclerosisCompletedPhase 2Travere Therapeutics, Inc.NCT01613118Written as IrbesartanHow we know
- Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedPhase 3Handok Inc.NCT05476354Written as IrbesartanHow we know
- Sacubitril/Valsartan for CKD5 Stage Dialysis PatientsCompletedPhase 4Ruijin HospitalNCT05243199Written as IrbesartanHow we know
- A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related GlomerulopathyTerminatedNot applicableZhi-Hong Liu, M.D.NCT02644486Written as IrbesartanHow we know
- Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney DiseaseStatus unknownEarly Phase 1Jiangsu Famous Medical Technology Co., Ltd.NCT03016832Written as irbesartan tabletsHow we know
- Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and HyperlipidemiaCompletedPhase 3Hanmi Pharmaceutical Company LimitedNCT01442987Written as IrbesartanHow we know
- A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes MellitusCompletedPhase 4NovartisNCT00660309Written as IrbesartanHow we know
- The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and HypertensionStatus unknownPhase 4Baker Heart and Diabetes InstituteNCT01360710Written as IrbesartanHow we know
- A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With HypertensionCompletedPhase 2Ligand PharmaceuticalsNCT00635232Written as irbesartanHow we know
Codes
What other systems call Irbesartan · ClinicalTrials.gg INT006715
- MeSH (NLM) D000077405IrbesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J0E2756Z7NIRBESARTANConfirmed FDA, NLM, Wikidata
- RxNorm 83818Confirmed FDA, Wikidata
- Wikidata Q947266irbesartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29130IrbesartanOne source FDA
- DrugBank DB01029One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077405 | Irbesartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J0E2756Z7N | IRBESARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 83818 | — | Confirmed FDA, Wikidata |
| Wikidata | Q947266 | irbesartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29130 | Irbesartan | One source FDA |
| DrugBank | DB01029 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.